All News #Library
Biotech
Promore Pharma Reports Outcome from Clinical Phase II Study with Ensereptide
20 Apr 2023 //
ACCESSWIRE
Promore`s phase 2 scar trial fail sends stock spiraling down
20 Apr 2023 //
FIERCE BIOTECH
Promore Reaches the Clean File Milestone in its Phase II Trial with Ensereptide
27 Feb 2023 //
ACCESSWIRE

Market Place
Sourcing Support